ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Iridocorneal Endothelial Syndrome

  • A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)
  • Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3
  • A Phase 1/ Phase 2 Study of TTHX1114(NM141)
  • Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
  • Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis
  • Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy
  • A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group